Why the study?
Specific imaging requirements are needed after implantation to assess the positioning and performance of the transcatheter EVOQUE tricuspid valve replacement system.
This review provides a comprehensive guide on the postoperative echocardiographic assessment of the EVOQUE tricuspid valve replacement system, focusing on device positioning, stability, and potential complications.
May aid standardized echo follow-up of approved EVOQUE implants; leaves open prospective validation of proposed positioning cutoffs.
The transcatheter EVOQUE tricuspid valve replacement system is an approved device for the treatment of patients with symptomatic severe tricuspid regurgitation despite medical therapy both in the United States and in Europe. Specific imaging requirements are needed in the screening and in the intraprocedural phase as well as to assess this valve after implantation, in order to assess its positioning and performance. In this review, focus will be on the postoperative echocardiographic assessment of device positioning and stability; evaluation of residual central tricuspid regurgitation or paravalvular leak; valve thrombosis/degeneration; interaction of the device frame with the right ventricle and adjacent structures, including the aortic valve and interventricular septum; and placement of pacemaker leads. This review will therefore be centered on these essential imaging aspects in the echocardiographic postimplantation evaluation of the EVOQUE valve.
No takes yet. Share an insight, caveat, or question.
Sannino et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: